Use of ECMO in Patients With Coronavirus Disease 2019: Does the Evidence Suffice?

Alom, Samiha; Haiduc, Ana Alina; Melamed, Naomi; Axiaq, Ariana; Harky, Amer

Alom, Samiha; Haiduc, Ana Alina; Melamed, Naomi; Axiaq, Ariana; Harky, Amer.

Alom S; St. George's, University of London, Cranmer Terrace, UK; School of Public Health, Imperial College London, South Kensington, UK.
Haiduc AA; St. George's, University of London, Cranmer Terrace, UK.
Melamed N; St. George's, University of London, Cranmer Terrace, UK.
Axiaq A; School of Medicine, Queen's University Belfast, Belfast, UK.
Harky A; Department of Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK; Department of Integrative Biology, Faculty of Life Sciences, University of Liverpool, Liverpool, UK; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, L

J Cardiothorac Vasc Anesth ; 35(4): 1256-1262, 2021 Apr.

Article in English | MEDLINE | ID: covidwho-745887

Subject(s)

COVID-19/therapy; Extracorporeal Membrane Oxygenation/adverse effects; SARS-CoV-2; COVID-19/diagnosis; Extracorporeal Membrane Oxygenation/methods; Humans; Respiratory Distress Syndrome/therapy; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Extracorporeal Membrane Oxygenation / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: J Cardiothorac Vasc Anesth Journal subject: Anesthesiology / Cardiology Year: 2021 Document Type: Article Affiliation country: J.jvca.2020.07.070

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google